Advanced Physical Therapy acquired by Illinois company
Bolingbrook, Ill.-based ATI Physical Therapy has acquired Advanced Physical Therapy, which has 175 employees and ranks among the city’s largest operators of physical therapy clinics.
Bolingbrook, Ill.-based ATI Physical Therapy has acquired Advanced Physical Therapy, which has 175 employees and ranks among the city’s largest operators of physical therapy clinics.
Marvin Pember, 58, is taking a new job near Philadelphia as the president of the acute care division of Universal Health Services Inc., a publicly traded company with 22 acute hospitals and numerous behavioral health centers spread from coast to coast.
Indianapolis-based Arcadia Resources Inc.’s auditor issued a “going-concern” warning Tuesday in the once-promising company’s annual report.
The U.S. Supreme Court has refused to revive a bid to press a $6.8 billion class-action suit against Eli Lilly and Co. over the marketing of Zyprexa, the company’s schizophrenia treatment.
Eli Lilly and Co., Amylin Pharmaceuticals Inc. and Alkermes Inc. said an analysis of a 148-patient trial found no evidence that their experimental Bydureon diabetes drug causes prolonged heart rhythms.
Eli Lilly and Co. and Boehringer Ingelheim GmbH’s Trajenta medicine for Type 2 diabetes has been recommended for approval in Europe, putting the drug on track to enter the region’s market this year.
Health insurer WellPoint Inc. has enlisted Google Maps for new websites that help patients think twice before they visit an emergency room for care that a less-expensive retail health clinic could handle.
Citizens Action Coalition Education Fund and Indiana Legal Services Inc. claim that “a good number” of Indianapolis south-side residents who should have qualified for reduced or waived bills at St. Francis were instead steered into payments plans.
Central Indiana Cancer Centers sold its five facilities to IU Health and transferred its 150 employees to the Indianapolis-based hospital system. The 16 physicians in the practice will remain independent, but they have signed a service agreement with IU Health that pulls the two entities into a tight embrace.
Medical imaging equipment maker Positron Corp. has agreed to move its operations to Noblesville, where it plans to invest $55 million to open a high-tech facility that will make isotopes used in cardiac PET scans.
Swiss health care giant Roche Holding AG has selected its diagnostics division in Indianapolis as the site for a new North America human resources center, a move that will add 50 employees to its local operations.
Drugmaker Eli Lilly and Co. has signed a deal with Swiss company Synthes Inc. to co-promote the bone drug Forteo and develop other potential orthopedic treatments.
Eli Lilly and Co. won a ruling in a lawsuit brought by Amylin Pharmaceuticals Inc., which wants to prevent Lilly from using the same people to sell Amylin’s diabetes drug and that of a competitor.
Earnings growth will continue to slow in 2011 for most of the industry’s biggest companies, analyst predicts.
Medco Health Solutions Inc., which operates a $140 million automated pharmacy and distribution center in Whitestown, has lost $3.5 billion in contracts since March.
Monday's Supreme Court decision is a victory for companies that collaborate with universities in research. Indianapolis-based Eli Lilly and Co. was among the companies that supported Roche.
Over the last three years, all major hospitals in Indianapolis have been active in hiring physicians. Competition was especially intense for cardiologists.
Roche Diagnostics Corp. landed an $11.4 million contract to provide laboratory testing services at military hospitals in the Washington, D.C., area.
Eli Lilly and Co. has agreed to license the U.S. marketing rights of its slow-selling sepsis drug Xigris to a newly created local biotech company called BioCritica that will seek to reinvigorate sales of the medication.
Eli Lilly and Co.’s Amyvid, an experimental imaging agent to detect signs of Alzheimer’s disease in the brain, shouldn’t be approved because of unreliable study results, a consumer-advocacy group said.